Neoadjuvant therapy and immunotherapy strategies for hepatocellular carcinoma.Ting Zhang, Xinting Sang, Haitao Zhao et al.|PubMed|2020Cited by 28
Evaluation of immune checkpoint inhibitor-associated hepatotoxic adverse events: A pharmacovigilance analysis based on the FAERS databaseZhihong Chen, Xin Lü, Junwei Zhang et al.|International Journal of Immunopathology and Pharmacology|2025Cited by 2